{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T23:58:58Z","timestamp":1783727938734,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,13]],"date-time":"2015-02-13T00:00:00Z","timestamp":1423785600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["mgmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.ymgme.2015.02.003","type":"journal-article","created":{"date-parts":[[2015,2,16]],"date-time":"2015-02-16T12:47:52Z","timestamp":1424090872000},"page":"557-563","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Long-term safety and efficacy of sapropterin: The PKUDOS registry experience"],"prefix":"10.1016","volume":"114","author":[{"given":"Nicola","family":"Longo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgianne L.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Pridjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M.","family":"Enns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Ficicioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L.","family":"Cohen-Pfeffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2001","key":"10.1016\/j.ymgme.2015.02.003_bb0005","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1542\/peds.108.4.972","article-title":"National Institutes of Health Consensus Development Conference Statement: phenylketonuria: screening and management, October 16\u201318, 2000","volume":"108","author":"National Institutes of Health Consensus Development Panel","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2015.02.003_bb0010","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/(SICI)1098-1004(200001)15:1<99::AID-HUMU18>3.0.CO;2-P","article-title":"PAHdb: a locus-specific knowledgebase","volume":"15","author":"Scriver","year":"2000","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2015.02.003_bb0015","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/gim.2013.157","article-title":"For the American College of Medical Genetics and Genomics Therapeutic Committee, phenylalanine hydroxylase deficiency diagnosis and management guideline","volume":"16","author":"Vockley","year":"2014","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2015.02.003_bb0020","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/gim.2013.179","article-title":"Recommendations for the nutrition management of phenylalanine hydroxylase deficiency","volume":"16","author":"Singh","year":"2014","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2015.02.003_bb0025","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ymgme.2007.05.006","article-title":"Phenylalanine blood levels and clinical outcomes in phenylketonuria: a systematic literature review and meta-analysis","volume":"92","author":"Waisbren","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2015.02.003_bb0030","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ymgme.2014.02.013","article-title":"Phenylketonuria Scientific Review Conference: state of the science and future research needs","volume":"112","author":"Camp","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2015.02.003_bb0035","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1056\/NEJMoa021654","article-title":"Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria","volume":"347","author":"Muntau","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2015.02.003_bb0040","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0140-6736(07)61234-3","article-title":"Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled study","volume":"370","author":"Levy","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2015.02.003_bb0045","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s10545-008-0940-8","article-title":"Significance of genotype in tetrahydrobiopterin-responsive phenylketonuria","volume":"32","author":"Trefz","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2015.02.003_bb0050","doi-asserted-by":"crossref","DOI":"10.1038\/gim.2014.109","article-title":"Long-term developmental progression in infants and young children taking sapropterin for phenylketonuria: a two-year analysis of safety and efficacy","author":"Longo","year":"2014","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2015.02.003_bb0055","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1002\/ajmg.a.32562","article-title":"Safety and efficacy of 22weeks of treatment with sapropterin dihydrochloride in patients with phenylketonuria","volume":"146A","author":"Lee","year":"2008","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ymgme.2015.02.003_bb0060","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ymgme.2011.03.020","article-title":"Safety of extended treatment with sapropterin dihydrochloride in patients with phenylketonuria: results of a phase 3b study","volume":"103","author":"Burton","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2015.02.003_bb0065","doi-asserted-by":"crossref","first-page":"e1881","DOI":"10.1542\/peds.2012-3291","article-title":"Long-term follow-up and outcome of phenylketonuria patients on sapropterin: a retrospective study","volume":"131","author":"Keil","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2015.02.003_bb0070","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ymgme.2014.02.016","article-title":"Sapropterin dihydrochloride use in pregnant women with phenylketonuria: an interim report of the PKU MOMS sub-registry","volume":"112","author":"Grange","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2015.02.003_bb0075","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.medcli.2011.03.037","article-title":"Treatment and control of patients with phenylketonuria: results from the Collaborative Group of Spanish Follow-up Units","volume":"138","author":"Campistol","year":"2012","journal-title":"Med. Clin."},{"key":"10.1016\/j.ymgme.2015.02.003_bb0080","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/978-1-4615-2960-6_52","article-title":"Tetrahydrobiopterin deficiency and an international database of patients","volume":"338","author":"Blau","year":"1993","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ymgme.2015.02.003_bb0085","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s10545-012-9464-3","article-title":"Efficacy and safety of BH4 before the age of 4years in patients with mild phenylketonuria","volume":"35","author":"Leuret","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2015.02.003_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2014.08.003","article-title":"Sapropterin Is safe and effective in patients less than 4-years-old with BH4-responsive phenylalanine hydroxylase deficiency","author":"Shintaku","year":"2014","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2015.02.003_bb0095","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s10545-007-0605-z","article-title":"The response of patients with phenylketonuria and elevated serum phenylalanine to treatment with oral sapropterin dihydrochloride (6R-tetrahydrobiopterin): a phase II, multicentre, open-label, screening study","volume":"30","author":"Burton","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2015.02.003_bb0100","article-title":"Adherence to tetrahydrobiopterin therapy in patients with phenylketonuria","author":"Rohr","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2015.02.003_bb0105","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s10545-006-0096-3","article-title":"The spectrum of phenylalanine variations under tetrahydrobiopterin load in subjects affected by phenylalanine hydroxylase deficiency","volume":"29","author":"Leuzzi","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2015.02.003_bb0110","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/j.ymgme.2005.06.008","article-title":"Tetrahydrobiopterin-responsive phenylketonuria: the New South Wales experience","volume":"86","author":"Mitchell","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2015.02.003_bb0115","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/j.ymgme.2005.05.013","article-title":"Long-term treatment with tetrahydrobiopterin increases phenylalanine tolerance in children with severe phenotype of phenylketonuria","volume":"86","author":"Hennermann","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2015.02.003_bb0120","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1023\/A:1010371002631","article-title":"A structural hypothesis for BH4 responsiveness in patients with mild forms of hyperphenylalaninaemia and phenylketonuria","volume":"24","author":"Erlandsen","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2015.02.003_bb0125","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1006\/mgme.2001.3294","article-title":"Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency: possible regulation of gene expression in a patient with the homozygous L48S mutation (letter)","volume":"75","author":"Blau","year":"2002","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2015.02.003_bb0130","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/humu.22320","article-title":"Tetrahydrobiopterin, its mode of action on phenylalanine hydroxylase, and importance of genotypes for pharmacological therapy of phenylketonuria","volume":"34","author":"Heintz","year":"2013","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2015.02.003_bb0135","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1086\/301638","article-title":"Human phenylalanine hydroxylase mutations and hyperphenylalaninemia phenotypes: a metanalysis of genotype-phenotype correlations","volume":"61","author":"Kayaalp","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2015.02.003_bb0140","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.ymgme.2005.09.002","article-title":"Delivery of exogenous tetrahydrobiopterin (BH4) to cells of target organs: role of salvage pathway and uptake of its precursor in effective elevation of tissue BH4","volume":"86","author":"Hasegawa","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2015.02.003_bb0145","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.tips.2008.10.003","article-title":"Vascular protection by tetrahydrobiopterin: progress and therapeutic prospects","volume":"30","author":"Katusic","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ymgme.2015.02.003_bb0150","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ymgme.2004.03.006","article-title":"The metabolic and molecular bases of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency","volume":"82","author":"Blau","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2015.02.003_bb0155","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ymgme.2011.10.014","article-title":"START, a double blind, placebo-controlled pharmacogenetic test of responsiveness to sapropterin dihydrochloride in phenylketonuria patients","volume":"105","author":"Utz","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2015.02.003_bb0160","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/GIM.0b013e318159a355","article-title":"Blood phenylalanine monitoring for dietary compliance among patients with phenylketonuria: comparison of methods","volume":"9","author":"Gregory","year":"2007","journal-title":"Genet. Med."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719215000463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719215000463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T01:56:42Z","timestamp":1537840602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719215000463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S1096719215000463"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2015.02.003","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term safety and efficacy of sapropterin: The PKUDOS registry experience","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2015.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}